The Effect of Hyoscine Butyl Bromide on the First Stage of Labor in Term Pregnancies

This study focuses on the effects of a medication called Hyoscine Butyl Bromide, or Buscopan®, during the first stage of labor in term pregnancies. The aim is to understand if this drug can safely speed up the process of cervical effacement and dilatation, potentially shortening the labor duration. This research is important as it could provide a new option for managing labor, potentially benefiting pregnant individuals and their babies. The study also investigates whether the use of Hyoscine Butyl Bromide during labor increases any risks, such as blood loss, the need for Caesarean deliveries, or lower neonatal APGAR scores. The study is designed as a double-blind, randomized, controlled clinical trial. This means that participants are randomly assigned to one of two groups, with one group receiving Hyoscine Butyl Bromide and the other group receiving a placebo (a harmless substance like normal saline that has no effect). Neither the participants nor the researchers know who is receiving the medication or the placebo. The study measures the effectiveness of Hyoscine Butyl Bromide by observing changes in cervical effacement and dilatation, and the overall duration of the first stage of labor. It also monitors for any potential complications to ensure the safety of both the mother and the baby.